United States - English - NLM (National Library of Medicine)

universal companies, inc. - lidocaine 4% - topical anesthetic for the temporary relief of discomfort and pain in large quantities, particularly over raw surfaces or blistered areas - skin becomes irritated - condition worsens or symptoms last more than 7 days - symptoms clear up and reoccur within a few days

United States - English - NLM (National Library of Medicine)

uriel pharmacy inc. - lead (unii: 2p299v784p) (lead - unii:2p299v784p) - lead 5 [hp_x] in 1 g - directions: for topical use only. use: temporary relief of headache.

United States - English - NLM (National Library of Medicine)

true botanica, llc - lead (unii: 2p299v784p) (lead - unii:2p299v784p) - lead 30 [hp_x] in 23 g - enter section text here for temporary relief of dizziness.  supports aging memory.  may also be used for standard homeopathic indications or as directed by your physician. tamper evident: do not use if safety seal is broken before first use.

United States - English - NLM (National Library of Medicine)

white manufacturing inc. dba micro-west - plumbum metallicum 12x, 30x, 200c, 1m - for the temporary relief of mental depression, slow perception, swollen gums, excessive colic and constipation for the temporary relief of mental  depression, slow perception,  swollen gums, excessive colic, and constipation

United States - English - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride extended-release tablets (sr) are indicated for the treatment of major depressive disorder (mdd), as defined by the diagnostic and statistical manual (dsm) . the efficacy of bupropion in the treatment of a major depressive episode was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult subjects with mdd [see clinical studies (14) ]. the efficacy of bupropion hydrochloride extended-release tablets (sr) in maintaining an antidepressant response for up to 44 weeks following 8 weeks of acute treatment was demonstrated in a placebo-controlled trial [see clinical studies (14) ]. pregnancy category c risk summary data from epidemiological studies of pregnant women exposed to bupropion in the first trimester indicate no increased risk of congenital malformations overall. all pregnancies, regardless of drug exposure, have a background rate of 2% to 4% for major malformations, and 15% to 20% for pregnancy loss. no clear evidence of teratogeni

United States - English - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride extended-release tablets (sr) are indicated for the treatment of major depressive disorder (mdd), as defined by the diagnostic and statistical manual (dsm) . the efficacy of bupropion in the treatment of a major depressive episode was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult subjects with mdd [see clinical studies (14) ]. the efficacy of bupropion hydrochloride extended-release tablets (sr) in maintaining an antidepressant response for up to 44 weeks following 8 weeks of acute treatment was demonstrated in a placebo-controlled trial [see clinical studies (14) ]. pregnancy category c risk summary data from epidemiological studies of pregnant women exposed to bupropion in the first trimester indicate no increased risk of congenital malformations overall. all pregnancies, regardless of drug exposure, have a background rate of 2% to 4% for major malformations, and 15% to 20% for pregnancy loss. no clear evidence of teratogeni

Australia - English - Department of Health (Therapeutic Goods Administration)

noble medical pty ltd atf noble medical trust&church nominees pty ltd atf southern surgical trust&tremedico pty ltd atf trevor white family trust - 31723 - suction system filter, smoke plume particulate - intended to extract particulates from the plume of smoke created during surgical procedures

United States - English - NLM (National Library of Medicine)

st. mary's medical park pharmacy - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride extended-release tablets (sr) are indicated for the treatment of major depressive disorder (mdd), as defined by the diagnostic and statistical manual (dsm ) . the efficacy of bupropion in the treatment of a major depressive episode was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult subjects with mdd [see clinical studies ( 14) ] . the efficacy of bupropion hydrochloride extended-release tablets (sr) in maintaining an antidepressant response for up to 44 weeks following 8 weeks of acute treatment was demonstrated in a placebo-controlled trial [see clinical studies ( 14) ]. - bupropion hydrochloride extended-release tablets (sr) are contraindicated in patients with a seizure disorder. - bupropion hydrochloride extended-release tablets (sr) are contraindicated in patients with a current or prior diagnosis of bulimia or anorexi

United States - English - NLM (National Library of Medicine)

clinical solutions wholesale, llc - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride extended-release tablets (sr) are indicated for the treatment of major depressive disorder (mdd), as defined by the diagnostic and statistical manual (dsm ) . the efficacy of bupropion in the treatment of a major depressive episode was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult subjects with mdd [ seeclinical studies ( 14)] . the efficacy of bupropion hydrochloride extended-release tablets (sr) in maintaining an antidepressant response for up to 44 weeks following 8 weeks of acute treatment was demonstrated in a placebo-controlled trial [ seeclinical studies ( 14)]. - bupropion hydrochloride extended-release tablets (sr) are contraindicated in patients with a seizure disorder. - bupropion hydrochloride extended-release tablets (sr) are contraindicated in patients with a curr

United States - English - NLM (National Library of Medicine)

bel-art products - water (unii: 059qf0ko0r) (water - unii:059qf0ko0r) - purpose emergency eyewash and skin flush uses for flushing the eye and skin to reduce chances of severe injury caused by acid, alkali, or particulate contamination. do not use • for injection • in intraocular surgery • internally • if solution changes color or becomes cloudy.